Tissue rigidity promotes tumor progression

September 19, 2005

Most investigations into cancer have focused on chemical signals, but a new research study provides rare insight into how mechanical force can regulate cellular behavior.

The study uncovers a link between tissue tension and tumor formation, suggesting that the stiffness of a tissue can influence molecular signals that promote the malignant behavior of tumor cells. The findings, published in the September issue of Cancer Cell, provide exciting new insight into the mechanisms that link the tissue microenvironment with tumorigenesis, and may identify new targets for tumor therapies.

Tumors are more rigid than normal tissues, and palpation of compliant tissues to look for a rigid tissue mass has been used as a method of cancer detection for some time. However, the relationship between tissue stiffness and the behavior of tumor cells is not well understood. Dr. Valerie M. Weaver, from the University of Pennsylvania in Philadelphia, and colleagues examined cancer cells developing within a three-dimensional gel system in which rigidity could be carefully controlled to look at how tissue stiffening might drive malignant behavior of cancer cells.

Research focused on a class of molecules called integrins that function as transducers of physical cues and are known to regulate growth factor signaling. The researchers found that even a slight increase in the stiffness of the surrounding matrix perturbed tissue architecture and enhanced growth by inducing Rho-generated cytoskeletal tension to promote assembly of integrin-associated attachments called focal adhesions and increase growth factor-dependent ERK activation. Further, a decrease in Rho or ERK activity in cancerous cells was associated with a subsequent decline of focal adhesions and a reversion of aberrant morphological structures.

The results of the research study provide a link between exogenous force, Rho-associated cytoskeletal tension, focal adhesions, and growth factor activation of ERK, and offer a fresh perspective for understanding the molecular basis of tissue differentiation and tumor formation. According to Dr. Weaver, "ERK and Rho appear to be part of an integrated mechanoregulatory circuit that functions to link physical cues through integrins to molecular pathways that control cell growth. A chronic increase in cytoskeletal tension could enhance growth and perturb tissue organization, thereby promoting malignant transformation of a tissue."
The researchers include Matthew J. Paszek, Nastaran Zahir, Kandice R. Johnson, Johnathon N. Lakins, Gabriela I. Rozenberg, Cynthia A. Reinhart-King, Susan S. Margulies, David Boettiger, Daniel A. Hammer, and Valerie M. Weaver of the University of Pennsylvania in Philadelphia, Pennsylvania; Amit Gefen of Tel Aviv University in Tel Aviv, Israel; and Micah Dembo of Boston University in Boston, Massachusetts. This work was supported by NIH grant CA078731 and DOD grants DAMD1701-1- 0368, 1703-1-0496, and W81XWH-05-1-330 to V.M.W.; NIH grants HL57204 (to S.S.M.), GM57388 (to D.B.), BRP HL6438801A1 (to V.M.W. and D.A.H.), and T32HL00795404 (to N.Z. and K.R.J.); and DOD grants DAMD17-01-1-0367 and 17-03-1-0421 to J.N.L. and G.I.R.

Paszek et al.: "Tensional homeostasis and the malignant phenotype" Publishing in Cancer Cell, Vol. 8, September 2005, pages 241-254. DOI 10.1016/j.ccr.2005.08.010 www.cancercell.org

Cell Press

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.